Hyderabad: Prime Minister Narendra Modi visited the bharat Biotech facility in Genome Valley to review the covid-19 vaccine development. Indigenous covid-19 vaccine has been developed by Bharat Biotech in collaboration with ICMR-National Institute of Virology. covaxin has attracted interest from many countries around the world for supply and introduction.
PM Narendra Modi tweeted, “At the bharat Biotech facility in Hyderabad, information was given about their indigenous covid-19 vaccine. Congratulations to the scientists for their progress in the tests conducted so far. His team is working closely with ICMR to make quick progress. “
He spoke to Dr. Krishna Ella, CMD, Suchitra Ella, Joint MD and Dr. V Krishna Mohan, ED of Bharat Biotech and scientists.
Bharat Biotech said, “We are very happy with the visit of PM Narendra Modi to bharat Biotech manufacturing facility in Hyderabad, Genome Valley. bharat biotech is a leader in pandemic vaccines and we are truly honored with this recognition. The Prime Minister’s visit is a great inspiration for our team and further strengthens our commitment to scientific discovery, solving public health issues, and the nation’s fight against covid-19. “
covaxin, India’s first indigenous vaccine with phase 3 clinical trials, is the first, largest and only efficacy trial in the developing world, involving a large number of volunteers at 25 sites. The vaccine will be produced at the only biosafety level 3 production facility in the world.Phase III trial is being conducted across India with 26,000 participants
company said that “We take this opportunity to thank the Government of India, the regulators, our vaccine development partners, the medical fraternity, the medical investigators, including the hospitals for their relentless support and cooperation in the development of vaccines for patients, covaxin Phase 3 clinical trials for “.
